Clinical Template Series

New Patient Psychiatric Evaluation

Complete H&P template for initial psychiatric evaluation in outpatient telepsychiatry and in-person settings. Designed for NPs. Includes MSE, risk assessment, biopsychosocial formulation, and billing support.

DSM-5-TR / ICD-10-CM
Columbia C-SSRS Framework
Telepsychiatry + In-Person
E&M Billing Ready

Encounter Mode Selection

Why This Matters Telepsychiatry and in-person evaluations have different documentation requirements. Telehealth requires documentation of patient location, provider location, platform used, and verbal consent to telehealth services. In-person requires physical proximity attestation and may include physical exam elements.
Telepsychiatry Header
// Insert at top of note ENCOUNTER TYPE: Telepsychiatry — Initial Psychiatric Evaluation DATE: [DATE] | TIME: [START TIME] – [END TIME] PLATFORM: [Doxy.me / Zoom for Healthcare / Epic MyChart Video / Other] PATIENT LOCATION: [City, State — patient confirmed home address] PROVIDER LOCATION: [Clinic Name, City, State] MODALITY: Synchronous audio-video (two-way interactive) CONSENT TO TELEHEALTH: Patient verbally confirmed understanding of telehealth services, privacy limitations, and right to receive in-person care. Consent obtained and documented. TECHNICAL QUALITY: Audio: [Clear/Intermittent] Video: [Clear/Intermittent/Audio-Only] IDENTITY VERIFIED: [Date of birth / Photo ID shown on camera] EMERGENCY PROTOCOL REVIEWED: Patient confirmed local ER: [Hospital Name]. Crisis line reviewed: 988 Suicide & Crisis Lifeline.
In-Person Header
// Insert at top of note ENCOUNTER TYPE: In-Person — Initial Psychiatric Evaluation DATE: [DATE] | TIME: [START TIME] – [END TIME] LOCATION: [Clinic Name, Address] ACCOMPANYING PERSON: [Name, relationship — or "Patient seen alone"] PATIENT VERIFIED: [Photo ID reviewed / Date of birth confirmed] VITALS (if obtained): BP: [___] | HR: [___] | Wt: [___] | BMI: [___] | SpO2: [___]
1

Demographics & Referral

Patient Demographics
PATIENT: [Full Name] DOB: [MM/DD/YYYY] | AGE: [##] | SEX: [M/F/Other] GENDER IDENTITY: [as reported] | PRONOUNS: [he/him / she/her / they/them] PREFERRED NAME: [if different] MRN: [___________] REFERRAL SOURCE: [Self / PCP / Therapist / ER / Insurance / Other: _____] REFERRING PROVIDER: [Name, credentials, practice] PRIMARY CARE PROVIDER: [Name, phone, fax] THERAPIST/COUNSELOR: [Name, phone — or "None identified"] INSURANCE: [Payer, plan, ID#] LEGAL STATUS: [Voluntary / Involuntary / Guardian — specify] INTERPRETER NEEDED: [No / Yes: Language _____, Mode: Phone/Video/In-person]
2

Chief Complaint & History of Present Illness

Why Document This Way The HPI must establish medical necessity. Onset, duration, severity, associated symptoms, and functional impairment are the pillars of complexity that justify the level of service billed. "Patient presents with depression" is insufficient. Quantify everything possible.
Chief Complaint
CHIEF COMPLAINT: [Patient's own words in quotes] // Example: "I've been depressed for months and my doctor said I should see a psychiatrist."
History of Present Illness
HISTORY OF PRESENT ILLNESS: [Patient Name] is a [age]-year-old [gender] with [no/a] prior psychiatric history, presenting for initial psychiatric evaluation with chief complaint of [CC]. ONSET: Symptoms began approximately [timeframe] ago. [Acute vs. gradual onset]. Precipitating factors: [life stressor / medical event / medication change / unknown]. COURSE: [Episodic / Persistent / Progressive / Fluctuating]. [Best period in past month]. [Worst period]. SEVERITY: Patient rates current [mood/anxiety/etc.] as [#]/10. [PHQ-9 score: ## — severity level]. [GAD-7 score: ## — severity level]. ASSOCIATED SYMPTOMS: Neurovegetative: [Sleep: ↑/↓/normal | Appetite: ↑/↓/normal | Energy: ↑/↓/normal] Cognitive: [Concentration: impaired/intact | Memory: concerns/intact] Psychomotor: [Agitation / Retardation / Normal] Hedonic: [Anhedonia present/absent] Somatic: [Headaches / GI / Pain / Other] FUNCTIONAL IMPACT: Work/School: [Unable to work / Decreased productivity / Missing ## days/month] Relationships: [Conflict / Withdrawal / Stable] Self-care: [Intact / Impaired — describe] ADLs: [Independent / Requires assistance] TREATMENT TO DATE: Prior medication trials: [See Past Psychiatric History] Current medications for psychiatric symptoms: [List or "None"] Current therapy: [Yes: type, frequency / No] Patient's response to prior treatment: [described in past psych hx] PATIENT'S GOALS FOR TREATMENT: "[Patient's own words]"
3

Psychiatric Review of Systems

Why Screen All Domains A complete psychiatric ROS protects you legally and clinically. Missed bipolar disorder, undetected psychosis, or undisclosed PTSD can derail treatment and expose you to liability. Document what you asked, what was endorsed, and what was denied.
Psychiatric Review of Systems
PSYCHIATRIC REVIEW OF SYSTEMS: [ MOOD ] Depressed mood: [+/-] Duration: [___] Anhedonia: [+/-] Hopelessness: [+/-] Worthlessness/guilt: [+/-] Elevated/euphoric mood: [+/-] // Screen for mania — see below Irritability: [+/-] Mood lability: [+/-] [ ANXIETY ] Excessive worry (GAD): [+/-] About: [___] Panic attacks: [+/-] Frequency: [___] Last episode: [___] Social anxiety: [+/-] Specific phobias: [+/-] Specify: [___] OCD symptoms: [+/-] Obsessions: [___] / Compulsions: [___] Health anxiety: [+/-] [ MANIA / HYPOMANIA ] Decreased need for sleep: [+/-] Grandiosity: [+/-] Racing thoughts: [+/-] Pressured speech: [+/-] Increased goal-directed activity: [+/-] Impulsivity/risk-taking: [+/-] Hypersexuality: [+/-] Duration of episodes: [___] // If any positive: assess for Bipolar I vs II vs cyclothymia [ PSYCHOSIS ] Auditory hallucinations: [+/-] Content: [___] Frequency: [___] Visual hallucinations: [+/-] Other hallucinations: [+/-] Specify: [___] Delusions: [+/-] Type: [paranoid/grandiose/somatic/other] Ideas of reference: [+/-] Thought disorganization: [+/-] Derealization: [+/-] Depersonalization: [+/-] [ TRAUMA / PTSD ] History of trauma: [+/-] Type: [combat/abuse/accident/other] — patient's words Intrusive memories/flashbacks: [+/-] Nightmares: [+/-] Avoidance: [+/-] Hypervigilance: [+/-] Emotional numbing: [+/-] PC-PTSD-5 score: [___/5] // Positive ≥3 [ SUBSTANCE USE ] See Section 5 — Substance Use History (separate detailed assessment) [ EATING ] Restriction/fasting: [+/-] Binge eating: [+/-] Purging behaviors: [+/-] Body image disturbance: [+/-] Current weight concerns: [+/-] [ COGNITIVE ] Memory complaints: [+/-] Word-finding difficulty: [+/-] Executive function: [+/-] Concentration: [+/-] MoCA/MMSE (if assessed): [___] [ SLEEP ] Insomnia (onset/maintenance/terminal): [+/-] Hypersomnia: [+/-] Sleep apnea (dx'd or suspected): [+/-] Nightmares: [+/-] Parasomnias: [+/-] [ SOMATIC ] Unexplained physical symptoms: [+/-] Pain (chronic): [+/-] Location: [___] GI symptoms: [+/-] Fatigue: [+/-] [ SELF-HARM / SUICIDALITY ] // Detailed assessment in Risk Section — document brief screen here Current SI: [+/-] History of attempts: [+/-] Current NSSI: [+/-]
4

Past Psychiatric History

Why Document Prior Medication Trials Documenting prior medication trials with specific responses establishes the clinical reasoning for your current choices. Payers require this for prior authorizations. Legally, it shows you considered alternatives. Clinically, it informs your prescribing decisions.
Past Psychiatric History
PAST PSYCHIATRIC HISTORY: PRIOR DIAGNOSES: [List with approximate date of diagnosis] PSYCHIATRIC HOSPITALIZATIONS: [None / List: Hospital, Date, Duration, Reason, Voluntary/Involuntary, Discharge Rx] ER VISITS (psychiatric): [None / List: Date, Reason, Outcome] PARTIAL HOSPITALIZATION / IOP: [None / Program name, dates, completion status] OUTPATIENT TREATMENT HISTORY: [Prior psychiatrists/NPs: Names, approx. dates, reason for discontinuation] [Prior therapists: Names, modality, approx. dates] SUICIDE ATTEMPTS: [None / List each:] Date: [___] Method: [___] Medical severity: [ER/ICU/none] Precipitant: [___] Lethality: [low/moderate/high] Intent at time: [___] SELF-HARM (non-suicidal): [None / Type: ___, Frequency: ___, Last occurrence: ___, Currently active: Y/N] PRIOR MEDICATION TRIALS: // List ALL psychiatric medications — this protects you clinically and legally Drug | Dose | Duration | Reason Stopped | Response --------------|------------|------------|---------------------|------------------ [Medication] | [dose] | [duration] | [SE/ineffective/cost] | [helpful/not/partial] [Medication] | [dose] | [duration] | [reason] | [response] [Medication] | [dose] | [duration] | [reason] | [response] CURRENT PSYCHIATRIC MEDICATIONS (from prior provider): [List or "None"] PSYCHOTHERAPY HISTORY: [CBT / DBT / EMDR / Psychodynamic / Supportive / Other] Response: [helpful/partially helpful/not engaged]
5

Substance Use History

Why Screen Systematically Substance use affects psychiatric diagnosis (substance-induced vs. independent disorders), medication choices (interactions, contraindications), and safety planning. CAGE-AID and AUDIT-C are validated, brief, and defensible in the medical record.
Substance Use Assessment
SUBSTANCE USE HISTORY: [ ALCOHOL ] Current use: [None / Social / Regular — ## drinks/week] Pattern: [Daily / Weekends / Binge (≥4W/≥5M per occasion)] AUDIT-C Score: [___/12] // ≥3W/≥4M = positive screen Q1 (frequency): [0-4] Q2 (drinks/day): [0-4] Q3 (heavy drinking days): [0-4] CAGE-AID: [___/4] // ≥2 = clinically significant Cut down: [Y/N] Annoyed: [Y/N] Guilty: [Y/N] Eye-opener: [Y/N] Last drink: [___] Blackouts: [Y/N] Withdrawal hx: [Seizures: Y/N | DTs: Y/N | CIWA required: Y/N] Prior treatment: [AA / Detox / MAT — specify] [ CANNABIS ] Current use: [None / Y — frequency: ___, form: ___, potency: ___] Age of first use: [___] Method: [smoked/vaped/edibles] Last use: [___] Perceived benefit: [pain/sleep/anxiety/mood/other] [ STIMULANTS ] Cocaine/crack: [None / Y — frequency: ___, route: ___, last use: ___] Amphetamines (illicit): [None / Y — frequency: ___, last use: ___] Methamphetamine: [None / Y] [ OPIOIDS ] Prescription opioids (non-prescribed): [None / Y — drug: ___, freq: ___] Heroin: [None / Y — route: ___, last use: ___] Fentanyl (illicit): [None / Y] Overdose history: [None / Y — date(s), required naloxone: Y/N] Current MAT: [Buprenorphine / Methadone / Naltrexone — provider: ___] [ BENZODIAZEPINES / SEDATIVES ] Prescribed: [None / Y — drug: ___, dose: ___, prescriber: ___] Non-prescribed: [None / Y — source: ___, frequency: ___] [ TOBACCO / NICOTINE ] Current: [Never / Former (quit ___) / Current — PPD: ___, years: ___] NRT/cessation: [Y — product: ___ / N] [ OTHER ] Hallucinogens: [None / Y — substance: ___, last use: ___] Dissociatives (ketamine, PCP): [None / Y] Inhalants: [None / Y] Other: [___] SUBSTANCE USE DISORDER DIAGNOSES: [List or "None identified at this time"] IN RECOVERY: [N/A / Y — duration: ___, supports: ___] NALOXONE: [Prescribed: Y/N | Patient has access: Y/N | Education provided: Y/N]
6

Medical History, Surgical History & Allergies

Medical / Surgical / Allergies
PAST MEDICAL HISTORY: [Condition 1 — year diagnosed, current treatment] [Condition 2] [None reported / See PCP records] PAST SURGICAL HISTORY: [Procedure — year] [None] CURRENT MEDICATIONS (all): Drug | Dose | Frequency | Prescriber | Indication --------------------|-----------|-----------|-------------------|------------ [Medication] | [dose] | [freq] | [provider] | [reason] [Medication] | [dose] | [freq] | [provider] | [reason] OTC/Supplements: [List] ALLERGIES / ADVERSE REACTIONS: Drug: [Name] — Reaction: [___] — Severity: [mild/moderate/severe/anaphylaxis] NKDA (no known drug allergies) / NKA RELEVANT LABS (recent, if available): CMP: [date / values] CBC: [date / values] TSH: [date / value] Lipids: [date / values] HbA1c: [date / value] Other: [___] CARDIAC HISTORY: [None / Arrhythmia / QTc prolongation concern / HTN / Other] // Important for stimulants, antipsychotics, TCAs, lithium NEUROLOGICAL HISTORY: [None / Seizures / TBI / Migraines / Other] // Seizure history affects Wellbutrin, clozapine dosing; TBI affects all psychiatric Rx REPRODUCTIVE HEALTH (if applicable): PREGNANCY STATUS: [Not pregnant / Pregnant — GA: ___ weeks / Postpartum — ___ weeks] CONTRACEPTION: [None / Method: ___] // Critical for valproate, lithium, benzodiazepines, paroxetine counseling ENDOCRINE: Thyroid: [Normal/Hypothyroid/Hyperthyroid] Diabetes: [Y/N] HEPATIC/RENAL: [Normal / Impaired — affects medication dosing]
7

Family Psychiatric History

Clinical Value Family psychiatric history informs diagnostic formulation, helps predict medication response (pharmacogenetics by family history), and identifies genetic risk (e.g., first-degree relative with bipolar disorder increases patient risk ~10x). Ask specifically about suicides — families often don't volunteer this.
Family Psychiatric History
FAMILY PSYCHIATRIC HISTORY: Relative | Diagnosis | Medication Response / Notes ------------------|------------------------|------------------------------- Mother | [Depression/Bipolar/etc] | [Responded to sertraline / unknown] Father | [___] | [___] Sibling(s) | [___] | [___] Maternal side | [___] | [___] Paternal side | [___] | [___] Children | [___] | [___] FAMILY HISTORY OF SUICIDE: [None reported / Yes — Relationship: ___, Method: ___, Patient's age at time: ___] // Ask directly: "Has anyone in your family died by suicide?" FAMILY HISTORY OF SUBSTANCE USE DISORDER: [None / Yes — Relationship: ___, Substance: ___] FAMILY HISTORY UNKNOWN: [Adopted / Estranged / Unable to obtain]
8

Social History

Social History
SOCIAL HISTORY: [ LIVING SITUATION ] Housing: [Own home / Renting / With family / Homeless / Group home / Other] Stability: [Stable / At risk of eviction / Transitional] Household: [Lives alone / With partner / With children (ages: ___) / With parents] [ RELATIONSHIPS ] Relationship status: [Single / Partnered / Married / Divorced / Widowed] Quality: [Supportive / Conflicted / Isolated] Children: [None / Yes — ages: ___, custody: ___] Social support: [Strong / Limited / None identified] [ EDUCATION ] Highest level completed: [___] Currently enrolled: [Y/N] Field: [___] [ OCCUPATION ] Employment: [Full-time / Part-time / Unemployed / Disabled / Retired / Student] Occupation: [___] Work stress: [Low / Moderate / High — describe: ___] Currently on leave: [Y/N — FMLA/disability] [ FINANCIAL ] Insurance: [Commercial / Medicaid / Medicare / Uninsured] Financial stress: [None / Moderate / Significant] Medication cost concerns: [Y/N — addressed: ___] [ LEGAL ] Pending charges: [None / Yes — type: ___] Probation/parole: [None / Yes — PO: ___, conditions: ___] History of incarceration: [None / Yes — duration: ___] Restraining orders (as subject or recipient): [None / Yes] [ MILITARY ] Veteran: [Y/N] Branch: [___] Era: [___] Combat exposure: [Y/N] Deployment: [___] MST (military sexual trauma): [Declined to answer / None / Yes] Connected to VA: [Y/N] [ SPIRITUALITY / RELIGION ] Important to patient: [Y/N] Faith tradition: [___] Relevant to care: [___] [ CULTURAL BACKGROUND ] Ethnicity/cultural identity: [___] Cultural considerations for care: [___] Language preference: [___]
9

Developmental History

When to Expand Developmental history is always relevant but especially critical when diagnosing ADHD, autism spectrum disorders, personality disorders, or trauma-related conditions. Abbreviated in routine adult evaluations; expand when clinically indicated.
Developmental History
DEVELOPMENTAL HISTORY: [ CHILDHOOD ] Prenatal/birth complications: [None reported / ___] Developmental milestones: [Met on time / Delayed — specify: ___] Childhood behavioral issues: [None / ADHD symptoms / Conduct problems / Other] School performance: [Good / Average / Struggled — retained: Y/N] Special education services: [None / IEP / 504 — reason: ___] [ ADVERSE CHILDHOOD EXPERIENCES (ACEs) ] // Document sensitively — assess for trauma history Physical abuse: [Denied / Reported] Sexual abuse: [Denied / Reported / Declined to answer] Emotional abuse/neglect: [Denied / Reported] Household dysfunction: [Substance use in home: Y/N | DV: Y/N | Mental illness: Y/N] ACE Score (if assessed): [___/10] [ ADOLESCENCE ] First psychiatric symptoms: [Age: ___] Behavioral issues: [None / Conduct / Oppositional / Delinquency] Substance use onset: [Age: ___, Substance: ___] Sexual development: [Age-appropriate / Concerns: ___] [ RELATIONSHIPS / ATTACHMENT ] Primary attachment figure: [___] Quality of early attachment: [Secure / Insecure — describe: ___]
10

Mental Status Examination

MSE is Your Objective Data The MSE is the psychiatric equivalent of the physical exam. It is your direct clinical observation — not what the patient reports, but what you observed. Be specific and descriptive. Vague MSEs fail to support complexity billing and are indefensible in malpractice cases.
Mental Status Examination
MENTAL STATUS EXAMINATION: [ APPEARANCE ] Age: [Appears stated age / Older / Younger] Build: [Average / Thin / Overweight / Obese] Grooming: [Well-groomed / Adequate / Disheveled / Malodorous] Dress: [Appropriate / Casual / Inappropriate — describe] Eye contact: [Good / Poor / Avoidant / Intense] Psychomotor: [No abnormalities / Agitated / Retarded / Tremor / Restless] [ BEHAVIOR ] Cooperation: [Cooperative / Guarded / Hostile / Evasive] Attitude: [Pleasant / Irritable / Suspicious / Seductive / Childlike] Rapport: [Good / Fair / Difficult to establish] [ SPEECH ] Rate: [Normal / Rapid / Slow] Volume: [Normal / Loud / Soft] Rhythm: [Normal / Pressured / Halting / Dysarthric] Fluency: [Fluent / Word-finding difficulty / Other] Amount: [Normal / Verbose / Terse] [ MOOD (Subjective) ] Patient reports: "[In their words — e.g., depressed, anxious, fine, frustrated]" [ AFFECT (Objective) ] Quality: [Euthymic / Depressed / Anxious / Irritable / Elevated / Dysphoric / Flat] Range: [Full / Restricted / Blunted / Flat / Labile] Intensity: [Normal / Heightened / Diminished] Appropriateness: [Congruent with thought content / Incongruent — describe] Mood-affect congruence: [Congruent / Incongruent] [ THOUGHT PROCESS ] [Linear, logical, goal-directed] OR [Circumstantial / Tangential / Loose associations / Flight of ideas / Thought blocking / Perseveration / Poverty of thought / Disorganized] [ THOUGHT CONTENT ] SI: [None / Active — see Risk Assessment] HI: [None / Active — see Risk Assessment] Obsessions: [None / Present — content: ___] Phobias: [None / Present — ___] Delusions: [None / Present — type: Paranoid / Grandiose / Somatic / Referential] Content: [___] Preoccupations: [None / Present — ___] [ PERCEPTUAL DISTURBANCES ] Hallucinations: [None] AH: [None / Present — command: Y/N / content: ___] VH: [None / Present — ___] Other: [Tactile / Olfactory / Gustatory / None] Illusions: [None / Present] Derealization/Depersonalization: [None / Present] [ COGNITION ] Level of consciousness: [Alert / Drowsy / Other] Orientation: [×4: person, place, time, situation / Disoriented to: ___] Attention/concentration: [Intact / Impaired — WFST: ___] Memory — immediate: [Intact / Impaired — digit span: ___] Memory — short-term: [Intact / Impaired — 3-word recall at 5 min: ___/3] Memory — long-term: [Intact / Impaired] Fund of knowledge: [Intact / Limited] Abstract reasoning: [Intact / Concrete] Formal cognitive testing: [Not assessed / MoCA: ___/30 / MMSE: ___/30] [ INSIGHT ] [Full — acknowledges illness and need for treatment] [Partial — acknowledges problems but not psychiatric illness] [Poor — denies illness or need for treatment] [Absent — no recognition of problems] [ JUDGMENT ] [Good — realistic assessment of situations, appropriate decisions] [Fair — occasional lapses in judgment] [Poor — consistent poor decision-making, impulsive behavior] [Impaired — describe: ___] [ INTELLIGENCE (estimated) ] [Average / Above average / Below average — based on: vocabulary, history, education]
11

Risk Assessment

⚠ Legal Standard: A thorough, documented risk assessment is your primary protection against malpractice claims related to suicide. Document both the assessment AND your clinical reasoning. A patient dying by suicide after an inadequate risk assessment is a sentinel event. A patient dying after a thorough, documented assessment demonstrating reasonable clinical judgment is a tragedy that you are professionally protected from.
Columbia C-SSRS Framework The Columbia Suicide Severity Rating Scale (C-SSRS) is used by the FDA, Joint Commission, and is considered the standard of care. This template adapts the C-SSRS framework for documentation while adding HV risk assessment.
Risk Assessment — Columbia C-SSRS Framework
RISK ASSESSMENT: [ SUICIDAL IDEATION — C-SSRS ] Current SI: [None / Passive / Active without plan / Active with plan / Active with intent] If present: Intensity: [Brief/transient / Intermittent / Persistent] Frequency: [Rare / Several times/week / Daily] Duration: [Seconds / Minutes / Hours] Controllability: [Can control / Cannot control] Deterrents: [Family / Religion / Fear of pain / None identified] Reasons: [Reasons for living > dying / Equivocal / Reasons for dying predominate] Ideation type: Passive death wish: [Y/N] "I wish I were dead" Non-specific active SI: [Y/N] "I want to kill myself" without method SI with method (no plan): [Y/N] SI with method and plan: [Y/N] Plan: [___] SI with intent: [Y/N] SI with intent and plan: [Y/N] [ SUICIDAL BEHAVIOR — LIFETIME & RECENT ] Preparatory behaviors (recent 3 months): [None / Giving away possessions / Researching methods / Obtaining means / Goodbye letters] Aborted attempt (lifetime): [None / Yes — date: ___, circumstances: ___] Interrupted attempt (lifetime):[None / Yes] Actual attempt (lifetime): [None / Yes — number: ___, most lethal: ___] Most recent attempt: [N/A / Date: ___, Method: ___, Outcome: ___] [ HOMICIDAL IDEATION ] HI present: [None] If present: Target: [Specific (name: ___) / Non-specific] Plan: [None / Present: ___] Means/access: [None / Yes: ___] Intent: [None / Present] Action taken: [Duty to warn assessed: Y/N | Tarasoff obligation: Y/N] [ RISK STRATIFICATION ] Static risk factors (historical): [ ] Prior suicide attempt [ ] Chronic psychiatric illness [ ] Family hx of suicide [ ] History of trauma/abuse [ ] Chronic pain/physical illness [ ] Male sex assigned at birth [ ] Age (>45 or adolescent) [ ] LGBTQ+ identity (minority stress) [ ] Access to firearms [ ] History of impulsivity/violence Dynamic risk factors (current, modifiable): [ ] Current SI/plan/intent [ ] Active substance use [ ] Hopelessness [ ] Recent major loss/stressor [ ] Recent psychiatric hospitalization [ ] Recent overdose [ ] Social isolation [ ] Insomnia [ ] Recent medication change [ ] Treatment non-adherence [ ] Active psychosis [ ] Ongoing domestic violence Protective factors: [ ] Reasons for living [ ] Engaged in treatment [ ] Future orientation [ ] Strong social support [ ] Religious/spiritual beliefs [ ] Children at home [ ] Fear of death/pain [ ] No access to means [ ] Therapeutic alliance [ ] Problem-solving ability [ MEANS RESTRICTION COUNSELING ] Firearms in home: [Y/N] If Y: counseling provided re: securing/removing: [Y/N] Medication access: [Secured / Unsecured] Limiting quantities discussed: [Y/N] Other means: [Counseling provided: Y/N] [ OVERALL RISK LEVEL ] ACUTE RISK: [Low / Moderate / High / Imminent] CHRONIC RISK: [Low / Moderate / High] [ CLINICAL REASONING FOR RISK LEVEL ] [Patient presents with [risk level] acute risk for self-harm based on: [List key contributing factors]. Protective factors noted include [list]. Disposition is [outpatient/higher level of care] because [reasoning]. Patient [does/does not) meet criteria for involuntary hold based on [state law, criteria].] [ SAFETY PLAN ] Completed: [Y/N — if N, reason: ___] Warning signs identified: [___] Internal coping strategies: [___] Social supports: [Names, phone numbers] Professional contacts: [Therapist: ___, After-hours line: ___] Crisis resources provided: - 988 Suicide & Crisis Lifeline (call or text 988) - Crisis Text Line: Text HOME to 741741 - Local ER: [Hospital name] - 911 instructions given: [Y/N] Safety plan document: [Given to patient / Uploaded to chart]
12

Biopsychosocial Formulation

The Art of Psychiatry The formulation is where you synthesize all the data into a coherent clinical narrative. It demonstrates clinical reasoning and individualized assessment. A good formulation shows the examiner (and any future provider) WHY you diagnosed what you diagnosed and WHY you're recommending the treatment you're recommending. It also supports high-complexity billing.
Biopsychosocial Formulation
BIOPSYCHOSOCIAL FORMULATION: [ PREDISPOSING FACTORS ] Biological: [Genetic loading — FHx of ___; neurobiological vulnerabilities; medical comorbidities affecting brain: ___] Psychological: [Attachment style; early trauma; maladaptive schemas; temperament; cognitive style: ___] Social: [Adverse childhood experiences; poverty; discrimination; cultural factors; early relational trauma: ___] [ PRECIPITATING FACTORS ] What triggered this episode or this presentation: [Specific stressors, losses, life events, medication changes, substance use, medical events — with timeline] [ PERPETUATING FACTORS ] What is maintaining the problem: [Cognitive distortions; avoidance; social isolation; ongoing stressors; substance use; untreated medical conditions; lack of support: ___] [ PROTECTIVE FACTORS ] [Intelligence; motivation for treatment; social support; financial resources; spirituality; resilience; insight; employment: ___] [ DIAGNOSTIC SUMMARY ] [Patient Name] is a [age]-year-old [gender] presenting with a constellation of symptoms most consistent with [primary diagnosis]. The [duration] course, [characteristic features], and [ruling out alternatives] support this diagnosis over [differential]. Contributing factors include [predisposing] that created vulnerability, [precipitating] that triggered the current episode, and [perpetuating] factors that have maintained symptoms. Treatment prognosis is [good/fair/guarded] given [protective factors] balanced against [risk factors]. [ DIFFERENTIAL DIAGNOSIS CONSIDERED ] [Diagnosis 1] — Ruled out because: [___] [Diagnosis 2] — Ruled out because: [___] [Diagnosis 3] — Retained for monitoring: [___]
13

DSM-5-TR Diagnoses with ICD-10 Codes

Diagnostic Impression
DIAGNOSES: [ PSYCHIATRIC — PRIMARY ] Axis I (DSM-5-TR): [F32.1] Major Depressive Disorder, moderate, single episode [F33.1] Major Depressive Disorder, moderate, recurrent [F41.1] Generalized Anxiety Disorder [F40.10] Social Anxiety Disorder [F41.0] Panic Disorder [F43.10] PTSD [F31.81] Bipolar II Disorder [F90.0] ADHD, Predominantly Inattentive [F20.9] Schizophrenia [F60.3] Borderline Personality Disorder // Delete inapplicable codes; add applicable ones [ SUBSTANCE USE DISORDERS ] [F10.20] Alcohol Use Disorder, moderate [F12.20] Cannabis Use Disorder, moderate [F11.20] Opioid Use Disorder, moderate [F14.20] Cocaine Use Disorder [ MEDICAL — RELEVANT ] [E11.9] Type 2 Diabetes Mellitus [I10] Essential Hypertension [E03.9] Hypothyroidism // List all comorbid medical conditions that affect psychiatric care [ PSYCHOSOCIAL / Z CODES ] [Z56.0] Unemployment [Z63.0] Relationship problems with spouse/partner [Z62.810] Personal history of physical abuse in childhood [Z91.19] Non-adherence to medical treatment [Z87.39] Personal history of other mental/behavioral disorders
ICD-10 Quick Reference See bottom of page for common ICD-10 codes in outpatient psychiatry. Always use the most specific code available. Unspecified codes (e.g., F32.9) are acceptable initially but should be refined as diagnosis becomes clearer.
14

Treatment Plan

Medication Rationale = Legal Protection Document why you're prescribing what you're prescribing. FDA-approved vs. off-label, prior trial failures that led here, specific patient factors. This protects you from claims of inappropriate prescribing and supports prior authorizations.
Treatment Plan
TREATMENT PLAN: [ MEDICATION PLAN ] // Use the Risk/Benefit format for each medication decision ACTION: START [Medication] [Dose] [Frequency] Indication: [Diagnosis] — [FDA-Approved / Off-Label] Rationale: [Why this medication? Patient-specific factors, prior trial results, comorbidities, patient preference, formulary considerations] Risk/Benefit: Discussed risks including [specific side effects relevant to this patient]. Benefits of [symptom relief / functional improvement] outweigh risks. Patient understood and agreed to proceed. Questions answered. Monitoring: [What to monitor, when — labs, weight, BP, ECG, etc.] Instructions: [Take with/without food, timing, titration plan: ___] ACTION: START [Medication 2] [Dose] [Frequency] // Repeat for each medication started [ THERAPY REFERRAL ] [Not indicated at this time / Referred to: ___] Modality recommended: [CBT / DBT / CPT / EMDR / Psychodynamic / Supportive / Other] Rationale: [Why this modality for this patient/diagnosis] [ ADDITIONAL INTERVENTIONS ] Labs ordered: [CMP, CBC, TSH, lipids, HbA1c, other: ___] Referrals: [PCP for ___ / Neurology / Cardiology / Other: ___] Case management: [Not needed / Social work referral for: ___] Crisis resources: [988 / Safety plan completed] Sleep hygiene: [Discussed / Handout provided] Exercise recommendation: [30 min aerobic 3-5x/week — evidence for depression/anxiety] Psychoeducation: [Diagnosis education provided re: ___] Substance use: [SBIRT completed / Referred to: ___] [ FOLLOW-UP ] Next appointment: [Date / Timeframe: 2-4 weeks for new medications] Between-visit contact: [Patient may call ___ with concerns] Titration instructions: [If tolerated, increase [medication] to [dose] at [timeframe]] Red flags — when to seek immediate care: [Worsening SI / Manic symptoms / Severe medication side effects (rash, priapism, serotonin syndrome) / Psychotic symptoms / New neurological symptoms]
16

PDMP Documentation

PDMP Check Documentation
PDMP REVIEW: Date/time accessed: [MM/DD/YYYY HH:MM] Database accessed: [State name PDMP — e.g., Florida PDMP / PMP InterConnect] Patient identity confirmed: [Name, DOB, address matched] RESULTS: [ ] No controlled substance prescriptions in the past [90/180] days — consistent with history [ ] Controlled substances found — consistent with patient-reported medications: [List: Drug, Dose, Qty, Prescriber, Date, Pharmacy — noting anything notable] [ ] Unexpected finding identified: [Describe: multiple prescribers / excessive quantities / dangerous combinations / drug not reported by patient — and clinical response taken] CLINICAL RESPONSE TO PDMP: [No action needed — findings consistent with clinical presentation] [Clinical conversation conducted regarding: ___] [Prescribing adjusted based on PDMP findings: ___] [Referral to addiction specialist due to: ___] // If controlled substance is being prescribed, this must be completed // If patient is new, document PDMP check even if no controlled substance prescribed today
17

UDS Ordering Documentation

Urine Drug Screen Documentation
URINE DRUG SCREEN: ORDERED: [Y — see orders / N — not clinically indicated at this time] RATIONALE: [New patient baseline / Controlled substance prescribing / Clinical suspicion / Routine monitoring per treatment agreement] PANEL: [Standard 10-panel / Extended panel / Specific drugs: ___] COLLECTION:[In-office observed / Lab send-out / Point-of-care] // If prior UDS results available: PRIOR UDS RESULTS: Date: [___] Results: [Negative / Positive for: ___] Expected substances present: [Y/N — patient on ___] Unexpected substances: [None / ___] Clinical response: [Discussed with patient / No action needed / ___]
18

Billing Complexity Support

Why Document Complexity CMS E&M guidelines (2021+) use medical decision-making (MDM) OR total time to determine billing level. New patient initial psychiatric evals typically bill 99205 (high complexity) or 99204 (moderate). Document the complexity elements explicitly to support your billed code.
Billing Complexity Statement
BILLING INFORMATION: CPT CODE: [90791 — Initial psychiatric evaluation / 99205 — New patient, high complexity] TOTAL TIME: [Total face-to-face time: ## minutes] // Time-based billing: 90791 = 60-90 min typical; 99205 = 60-74 min MEDICAL DECISION MAKING (MDM) — for E&M billing: Problems addressed (supports complexity level): [ ] New problem — no established management plan (moderate-high) [ ] New problem with workup required (high) [ ] Chronic illness with severe exacerbation (high) [ ] Multiple comorbid psychiatric diagnoses (high) [ ] Psychiatric illness with medical comorbidities requiring coordination (high) Data reviewed: [ ] External records reviewed (prior records, collateral) [ ] Diagnostic test results reviewed (labs, prior assessments) [ ] Independent interpretation of diagnostic tests [ ] Discussed findings with interpreting provider Risk level: [ ] Prescription drug management (moderate-high) [ ] Drug requiring intensive monitoring (high — e.g., clozapine, lithium) [ ] Diagnosis or treatment significantly limited by social determinants [ ] Referral for hospital admission or emergency care discussed [ ] Controlled substance prescription (minimum moderate) SUPPORTING ELEMENTS DOCUMENTED: ✓ Comprehensive psychiatric history (multi-system review) ✓ Complete mental status examination ✓ Formal risk assessment with stratification ✓ Biopsychosocial formulation ✓ Multiple diagnoses addressed ✓ Medication management with risk/benefit discussion ✓ Safety planning completed ✓ Coordination with other providers (PCP, therapist) SUPERVISING PHYSICIAN (if applicable): [Collaborating physician: ___, MD/DO] [Attestation: Present / Reviewed and agree / Available for consultation]

Common ICD-10 Quick Reference

CodeDiagnosis
F32.0Major Depressive Disorder, single episode, mild
F32.1Major Depressive Disorder, single episode, moderate
F32.2Major Depressive Disorder, single episode, severe without psychosis
F33.0MDD, recurrent, current episode mild
F33.1MDD, recurrent, current episode moderate
F33.2MDD, recurrent, severe without psychosis
F41.1Generalized Anxiety Disorder
F41.0Panic Disorder
F40.10Social Anxiety Disorder, unspecified
F43.10Post-Traumatic Stress Disorder, unspecified
F31.81Bipolar II Disorder
F31.10Bipolar I Disorder, current episode manic, unspecified severity
F90.0ADHD, Predominantly Inattentive Presentation
F90.1ADHD, Predominantly Hyperactive-Impulsive
F90.2ADHD, Combined Presentation
F20.9Schizophrenia, unspecified
F25.9Schizoaffective Disorder, unspecified
F60.3Borderline Personality Disorder
F10.20Alcohol Use Disorder, moderate
F11.20Opioid Use Disorder, moderate, uncomplicated
F12.20Cannabis Use Disorder, moderate
F14.20Cocaine Use Disorder, moderate, uncomplicated
F50.01Anorexia Nervosa, restricting type
F50.2Bulimia Nervosa
F51.01Primary Insomnia
R45.851Suicidal ideation
T14.91Suicide attempt (use with external cause code)